NPPB and heart failure: Another interesting finding of this clinical trial is that the intensive but regular ATV combined with MNCs therapy can increase the area of viable myocardium at infarct region with reduction in scar size and blood level of heart failure biomarker NT-Pro BNP, suggesting the possibility of cardiac tissue repair and regeneration.